Hypertension in women: What is really known? The women's caucus, working group on Women's health of the Society of General Internal Medicine

Kathryn Anastos, Pamela Charney, Rita A. Charon, Ellen Cohen, Clara Y. Jones, Carola Marte, Deborah M. Swiderski, Mary E. Wheat, Sarah Williams

Research output: Contribution to journalArticle

159 Citations (Scopus)

Abstract

Purpose: To determine whether there is sufficient information in the medical literature to guide appropriate treatment of hypertensive women. Data Identification: Epidemiologic surveys of hypertension, clinical trials of antihypertensive therapy, and studies of selected adverse effects of antihypertensive agents were identified through a computerized search using MEDLINE and by identifying all studies cited in current medical textbooks as supporting evidence for the guidelines for the treatment of hypertensive individuals. All epidemiologic studies selected were cross-sectional or longitudinal, multicenter, population-based surveys. All clinical trials were large, randomized studies comparing one or more antihypertensive agents with a placebo or nonplacebo control group. Epidemiologic studies and clinical trials were reviewed to assess the quantity and quality of information available regarding important aspects of hypertension in women. Data pertaining to epidemiology, natural history, results of treatment, and two significant side effects of antihypertensive treatment were examined. Results of Data Analysis: The prevalence of hypertension is greater in black women than in black men and is about equal in white women and men. Because women outnumber men in the population, there are more hypertensive women than men. The attributable risk percent (the proportion of end points that could be eliminated by removing hypertension) for cardiovascular complications of hypertension is higher for women than men. Clinical trials show clear benefit of therapy for black women but no clear benefit for white women; some studies suggest that treatment of white women is harmful. Lipid profiles and their relation to ischemic heart disease differ for women and men; there is currently no information on the effects of antihypertensive agents on serum lipids in women. Few data have been published on the frequency of sexual dysfunction in treated hypertensive women. Conclusions: Hypertension in women and its related cardiovascular outcomes are a major public health problem. Clinical trials of antihypertensive therapy do not fully support current guidelines for the treatment of hypertensive women. Research concerning adverse effects of antihypertensive agents has largely excluded women from consideration; further studies are required to guide appropriate treatment.

Original languageEnglish (US)
Pages (from-to)287-293
Number of pages7
JournalAnnals of Internal Medicine
Volume115
Issue number4
StatePublished - Aug 15 1991

Fingerprint

Working Women
Women's Health
Hypertension
Antihypertensive Agents
Clinical Trials
Therapeutics
Epidemiologic Studies
Guidelines
Lipids
Textbooks

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hypertension in women : What is really known? The women's caucus, working group on Women's health of the Society of General Internal Medicine. / Anastos, Kathryn; Charney, Pamela; Charon, Rita A.; Cohen, Ellen; Jones, Clara Y.; Marte, Carola; Swiderski, Deborah M.; Wheat, Mary E.; Williams, Sarah.

In: Annals of Internal Medicine, Vol. 115, No. 4, 15.08.1991, p. 287-293.

Research output: Contribution to journalArticle

Anastos, Kathryn ; Charney, Pamela ; Charon, Rita A. ; Cohen, Ellen ; Jones, Clara Y. ; Marte, Carola ; Swiderski, Deborah M. ; Wheat, Mary E. ; Williams, Sarah. / Hypertension in women : What is really known? The women's caucus, working group on Women's health of the Society of General Internal Medicine. In: Annals of Internal Medicine. 1991 ; Vol. 115, No. 4. pp. 287-293.
@article{9e369d0131fd4a1c8606797884115429,
title = "Hypertension in women: What is really known? The women's caucus, working group on Women's health of the Society of General Internal Medicine",
abstract = "Purpose: To determine whether there is sufficient information in the medical literature to guide appropriate treatment of hypertensive women. Data Identification: Epidemiologic surveys of hypertension, clinical trials of antihypertensive therapy, and studies of selected adverse effects of antihypertensive agents were identified through a computerized search using MEDLINE and by identifying all studies cited in current medical textbooks as supporting evidence for the guidelines for the treatment of hypertensive individuals. All epidemiologic studies selected were cross-sectional or longitudinal, multicenter, population-based surveys. All clinical trials were large, randomized studies comparing one or more antihypertensive agents with a placebo or nonplacebo control group. Epidemiologic studies and clinical trials were reviewed to assess the quantity and quality of information available regarding important aspects of hypertension in women. Data pertaining to epidemiology, natural history, results of treatment, and two significant side effects of antihypertensive treatment were examined. Results of Data Analysis: The prevalence of hypertension is greater in black women than in black men and is about equal in white women and men. Because women outnumber men in the population, there are more hypertensive women than men. The attributable risk percent (the proportion of end points that could be eliminated by removing hypertension) for cardiovascular complications of hypertension is higher for women than men. Clinical trials show clear benefit of therapy for black women but no clear benefit for white women; some studies suggest that treatment of white women is harmful. Lipid profiles and their relation to ischemic heart disease differ for women and men; there is currently no information on the effects of antihypertensive agents on serum lipids in women. Few data have been published on the frequency of sexual dysfunction in treated hypertensive women. Conclusions: Hypertension in women and its related cardiovascular outcomes are a major public health problem. Clinical trials of antihypertensive therapy do not fully support current guidelines for the treatment of hypertensive women. Research concerning adverse effects of antihypertensive agents has largely excluded women from consideration; further studies are required to guide appropriate treatment.",
author = "Kathryn Anastos and Pamela Charney and Charon, {Rita A.} and Ellen Cohen and Jones, {Clara Y.} and Carola Marte and Swiderski, {Deborah M.} and Wheat, {Mary E.} and Sarah Williams",
year = "1991",
month = "8",
day = "15",
language = "English (US)",
volume = "115",
pages = "287--293",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "4",

}

TY - JOUR

T1 - Hypertension in women

T2 - What is really known? The women's caucus, working group on Women's health of the Society of General Internal Medicine

AU - Anastos, Kathryn

AU - Charney, Pamela

AU - Charon, Rita A.

AU - Cohen, Ellen

AU - Jones, Clara Y.

AU - Marte, Carola

AU - Swiderski, Deborah M.

AU - Wheat, Mary E.

AU - Williams, Sarah

PY - 1991/8/15

Y1 - 1991/8/15

N2 - Purpose: To determine whether there is sufficient information in the medical literature to guide appropriate treatment of hypertensive women. Data Identification: Epidemiologic surveys of hypertension, clinical trials of antihypertensive therapy, and studies of selected adverse effects of antihypertensive agents were identified through a computerized search using MEDLINE and by identifying all studies cited in current medical textbooks as supporting evidence for the guidelines for the treatment of hypertensive individuals. All epidemiologic studies selected were cross-sectional or longitudinal, multicenter, population-based surveys. All clinical trials were large, randomized studies comparing one or more antihypertensive agents with a placebo or nonplacebo control group. Epidemiologic studies and clinical trials were reviewed to assess the quantity and quality of information available regarding important aspects of hypertension in women. Data pertaining to epidemiology, natural history, results of treatment, and two significant side effects of antihypertensive treatment were examined. Results of Data Analysis: The prevalence of hypertension is greater in black women than in black men and is about equal in white women and men. Because women outnumber men in the population, there are more hypertensive women than men. The attributable risk percent (the proportion of end points that could be eliminated by removing hypertension) for cardiovascular complications of hypertension is higher for women than men. Clinical trials show clear benefit of therapy for black women but no clear benefit for white women; some studies suggest that treatment of white women is harmful. Lipid profiles and their relation to ischemic heart disease differ for women and men; there is currently no information on the effects of antihypertensive agents on serum lipids in women. Few data have been published on the frequency of sexual dysfunction in treated hypertensive women. Conclusions: Hypertension in women and its related cardiovascular outcomes are a major public health problem. Clinical trials of antihypertensive therapy do not fully support current guidelines for the treatment of hypertensive women. Research concerning adverse effects of antihypertensive agents has largely excluded women from consideration; further studies are required to guide appropriate treatment.

AB - Purpose: To determine whether there is sufficient information in the medical literature to guide appropriate treatment of hypertensive women. Data Identification: Epidemiologic surveys of hypertension, clinical trials of antihypertensive therapy, and studies of selected adverse effects of antihypertensive agents were identified through a computerized search using MEDLINE and by identifying all studies cited in current medical textbooks as supporting evidence for the guidelines for the treatment of hypertensive individuals. All epidemiologic studies selected were cross-sectional or longitudinal, multicenter, population-based surveys. All clinical trials were large, randomized studies comparing one or more antihypertensive agents with a placebo or nonplacebo control group. Epidemiologic studies and clinical trials were reviewed to assess the quantity and quality of information available regarding important aspects of hypertension in women. Data pertaining to epidemiology, natural history, results of treatment, and two significant side effects of antihypertensive treatment were examined. Results of Data Analysis: The prevalence of hypertension is greater in black women than in black men and is about equal in white women and men. Because women outnumber men in the population, there are more hypertensive women than men. The attributable risk percent (the proportion of end points that could be eliminated by removing hypertension) for cardiovascular complications of hypertension is higher for women than men. Clinical trials show clear benefit of therapy for black women but no clear benefit for white women; some studies suggest that treatment of white women is harmful. Lipid profiles and their relation to ischemic heart disease differ for women and men; there is currently no information on the effects of antihypertensive agents on serum lipids in women. Few data have been published on the frequency of sexual dysfunction in treated hypertensive women. Conclusions: Hypertension in women and its related cardiovascular outcomes are a major public health problem. Clinical trials of antihypertensive therapy do not fully support current guidelines for the treatment of hypertensive women. Research concerning adverse effects of antihypertensive agents has largely excluded women from consideration; further studies are required to guide appropriate treatment.

UR - http://www.scopus.com/inward/record.url?scp=0025836341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025836341&partnerID=8YFLogxK

M3 - Article

C2 - 1854113

AN - SCOPUS:0025836341

VL - 115

SP - 287

EP - 293

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 4

ER -